When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
HOOK - Hookipa to commence additional arm in HB-201 trial for HPV+ cancers
HOOKIPA Pharma Inc.
The FDA clears Hookipa Pharma's (NASDAQ:HOOK) Investigational New Drug (IND) Application for HB-202, to initiate an additional arm in its Phase 1/2 clinical trial for HB-201 for the treatment of Human Papillomavirus 16-positive (HPV 16+) cancers.
More news on: HOOKIPA Pharma Inc., Healthcare stocks news, Stocks on the move,